• Acting Assistant Professor, Global Health
  • Senior Research Scientist, Kenya Medical Research Institute, Nairobi, Kenya
Select from the following:

Dr. Bhavna Chohan received her PhD (Virology) from University of Washington and MSc (Applied Molecular Biology of Infectious Diseases) from London School of Hygiene & Tropical Medicine, United Kingdom. She has been actively involved with HIV/STI research since 1993, serving as Research Laboratory Manager for collaborative research projects with Universities of Washington and Nairobi in Mombasa, Kenya. After her Graduate studies from University of Washington under the mentorship of Dr. Julie Overbaugh, she returned to Nairobi, Kenya in 2007, where she helped establish a molecular virology research laboratory. Her broad goals are to able establish and implement quality research on HIV transmission studies to improve health outcomes in Kenya and build a resource of well-trained and qualified scientists in the country.

Currently, Dr.Chohan serves as the Laboratory Director for the Universities of Nairobi/Washington collaborative research studies in Nairobi and also conducts funded research studies as the lead investigator for the NIH as well as local (Kenya) funded studies. She holds position of Senior Research Scientist position at Kenya Medical Research Institute (KEMRI) and visiting scientist at University of Nairobi. She provides lectures and mentors students and junior scientists at KEMRI. Her research interests have been focused on HIV transmission and drug resistance studies.

Country Affiliations 
  • Gujarati
  • Kiswahili
Health Topics 
  • Child and Adolescent Health (incl. Pediatrics)
  • Cost-effectiveness
  • Herpes
  • HIV Transmission
  • Infectious Diseases
  • Pathobiology
  • Prevention
  • Research
  • STDs (other than HIV)
  • Viruses

Chohan B, Tapia K, Benki-Nugent S, Khasimwa B, Nga’yo M, Maleche-Obimbo E, Wamalwa D, Overbaugh J, John-Stewart G. Nevirapine resistance in previously NVP-unexposed HIV-1 infected infants initiating early antiretroviral therapy. AIDS Res Hum Retroviruses. 2015;31(8):783-91. PMCID: PMC4533021.

Chohan BH, Tapia K, Merkel, M, Kariuki A, Khasimwa B, Olago A, Gichuhi R, Obimbo EM, and Wamalwa D. Pooled HIV-1 RNA viral load testing for detection of antiretroviral treatment failure in Kenyan children. J Acquir Immune Defic Syndr. 2013;63(3):e87-93. doi: 10.1097/QAI. 0b013e318292f9cd. PMCID: PMC3767042.

Piantadosi A*, Chohan B*, Chohan V, McClelland S, Overbaugh J. Chronic HIV-1 infection Fails to Protect against Superinfection. PloS Pathogens. 2007;3(11):e177. (*co-first authors). PMCID: PMC2077901.

Chohan B, Lang D, Sagar M, Korber B, Lavreys L, Richardson B, Overbaugh J. Selection for Human Immunodeficiency Virus Type 1 Envelope Glycosylation Variants with Shorter V1-V2 loops sequences occurs during transmission of Certain Genetic Subtypes and May Impact Viral RNA Levels. J Virol. 2005 May;79(10):6528-31. PMCID: PMC1091724.

Baeten J.Chohan B, Lavreys L, Chohan, V R. McClelland S, Certain L, Mandaliya K, Jaoko w, Overbaugh J. HIV-1 subtype D infection is associated with faster disease progression compared with subtype A in spite of similar HIV-1 plasma viral loads. J Infect Dis. 2007 Apr 15;195(8):1177-80. PMID: 17357054.